The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
Phase 2
- Conditions
- AcneInflammation
- Registration Number
- NCT00388778
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Acne
Exclusion Criteria
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie doxycycline's anti-inflammatory effects in acne treatment?
How does subantimicrobial doxycycline compare to standard antibiotic therapies for mild-moderate acne?
Are there specific biomarkers that predict response to low-dose doxycycline in acne patients?
What are the long-term safety profiles of 20mg vs 100mg doxycycline regimens for acne?
How does doxycycline's anti-inflammatory action compare to other tetracycline derivatives in acne treatment?
Trial Locations
- Locations (1)
Skin Research Center, Shaheed Beheshti Medical University
🇮🇷Tehran, Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University🇮🇷Tehran, Iran, Islamic Republic ofParviz Toossi, M.D.Principal InvestigatorNahid Mohtasham, MDSub Investigator